Literature DB >> 32618036

The annual incidence of Langerhans cell histiocytosis among adults living in Greece.

Polyzois Makras1, Dimitra Stathi2, Maria Yavropoulou1,3, Marina Tsoli1,3, Gregory Kaltsas1,3.   

Abstract

Langerhans cell histiocytosis (LCH) is a rare inflammatory myeloid neoplasia with a variable clinical course and outcome. Although there are some data regarding its incidence in children, such information in adults is lacking. To address the actual annual LCH incidence among adults, we prospectively recorded, during a 12-month period, any new case with a definitive histological diagnosis of LCH, among persons aged 18 and older living in Greece. Fourteen new cases were recorded corresponding to an annual incidence of 1.58 per million population. Female to male ratio was 1.34, and mean age at diagnosis was 43.5 years.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  Langerhans cell histiocytosis; adults; incidence

Mesh:

Year:  2020        PMID: 32618036     DOI: 10.1002/pbc.28422

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

Review 1.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

Review 2.  Multi-System Langerhans Cell Histiocytosis as a Mimic of IgG4-Related Disease: A Case Report and Literature Review.

Authors:  Xiaohui Feng; Lu Zhang; Fuqiong Chen; Gang Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

Review 3.  Spontaneous Thyroid Hemorrhage Caused by Langerhans Cell Histiocytosis: A Case Report and Literature Review.

Authors:  Jingying Zhang; Chengchen Wang; Chuanshuai Lin; Binglong Bai; Mao Ye; Dapeng Xiang; Zhiyu Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-19       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.